‘An attractive opportunity for investing’: Goldman Sachs closes $650M fund aimed at biotechs jwaldron Wed, 01/03/2024 - 09:14.: Goldman Sachs is planning to make a splash in the life sciences sector, taking in $650 million for its first fund aimed at the drug development space. The size of the West Street Life Sciences I fund, which overshot its original target, makes it one of the largest first-time private life sciences growth funds, Goldman Sachs Asset Management claimed in a Jan. 3 release.